Sujet(s)
Humains , Femelle , Dermatoses bactériennes/microbiologie , Dermatoses bactériennes/anatomopathologie , Infections à mycobactéries non tuberculeuses/microbiologie , Infections à mycobactéries non tuberculeuses/anatomopathologie , Biopsie , Résultat thérapeutique , Dermatoses bactériennes/traitement médicamenteux , Mycobacterium fortuitum/isolement et purification , Adulte d'âge moyen , Antibactériens/usage thérapeutique , Infections à mycobactéries non tuberculeuses/traitement médicamenteuxRÉSUMÉ
Abstract: Atypical mycobacterial infections are caused by mycobacteria other than those from the M. tuberculosis complex and M. leprae. Its incidence has increased progressively, with considerable increase of scientific publications on the subject. Only 10% of the cases present with cutaneous infections, most of them related to surgical interventions and aesthetic procedures. We present a case of mycobacteriosis due to automotive accident that presented a diagnostic challenge due to its clinical presentation with lesions of sporotrichoid progression in the lymphatic system.
Sujet(s)
Humains , Mâle , Adulte , Sporotrichose/anatomopathologie , Accidents de la route , Dermatoses bactériennes/anatomopathologie , Infections à mycobactéries non tuberculeuses/anatomopathologie , Sporotrichose/diagnostic , Sporotrichose/microbiologie , Dermatoses bactériennes/microbiologie , Illustration médicale , Infections à mycobactéries non tuberculeuses/complicationsRÉSUMÉ
ABSTRACT Objective: To describe the clinical manifestations of patients with pulmonary infection caused by mycobacteria of the Mycobacterium abscessus complex (MABSC), and to compare these manifestations with those of patients infected with other nontuberculous mycobacteria (NTM). Methods: This was a retrospective cohort study involving 43 patients divided into two groups: the MABSC group, consisting of patients with pulmonary infection caused by MABSC (n = 17); and the NTM group, consisting of patients with pulmonary infection caused by NTM other than MABSC (n = 26). Patients were previously treated with a regimen of rifampin, isoniazid, pyrazinamide, and ethambutol before the diagnosis of NTM was confirmed by two culture-positive sputum samples. The nucleotide sequences of the hsp65, 16S rRNA, and/or rpoB genes were analyzed to identify the mycobacteria. Data were collected on demographic, clinical, and radiological characteristics, as well as on treatment responses and outcomes. Results: Loss of appetite was the only clinical manifestation that was significantly more common in the MABSC group than in the NTM group (p = 0.0306). The chance of having to use a second treatment regimen was almost 12 times higher in the MABSC group than in the NTM group. Treatment success was significantly higher in the NTM group than in the MABSC group (83.2% vs. 17.6%; p < 0.0001). The chance of recurrence was approximately 37 times higher in the MABSC group than in the NTM group. Conclusions: In the study sample, treatment response of pulmonary disease caused by MABSC was less favorable than that of pulmonary disease caused by other NTM.
RESUMO Objetivo: Descrever as manifestações clínicas de pacientes com infecção pulmonar por micobactérias do complexo Mycobacterium abscessus (CMA) e compará-las com as daqueles infectados com outras micobactérias não tuberculosas (MNT). Métodos: Estudo de coorte retrospectivo envolvendo 43 pacientes divididos em dois grupos: grupo CMA, com pacientes com infecção pulmonar por CMA (n = 17); e grupo MNT, com pacientes com infecção pulmonar por MNT que não CMA (n = 26). Os pacientes foram previamente tratados com o esquema rifampicina, isoniazida, pirazinamida e etambutol antes de o diagnóstico de MNT ser confirmado com culturas positivas em duas amostras de escarro diferentes. As sequências nucleotídicas dos genes hsp65, RNAr 16S e/ou rpoB foram analisadas para a identificação das micobactérias. Foram coletadas características demográficas, clínicas e radiológicas, assim como respostas terapêuticas e desfechos. Resultados: A única manifestação clínica significativamente mais frequente no grupo CMA que no grupo MNT foi hiporexia (p = 0,0306). A chance de haver a necessidade de utilização de um segundo esquema terapêutico foi quase 12 vezes maior no grupo CMA que no grupo MNT. O sucesso terapêutico foi significativamente maior no grupo MNT que no grupo CMA (83,2% vs. 17,6%; p < 0,0001). A chance de recidiva no grupo CMA foi aproximadamente 37 vezes maior que no grupo MNT. Conclusões: Na amostra estudada, a resposta terapêutica da doença pulmonar causada por CMA evoluiu de forma menos favorável do que naquela causada pelas demais MNT.
Sujet(s)
Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Sujet âgé , Sujet âgé de 80 ans ou plus , Jeune adulte , Mycobacterium abscessus/isolement et purification , Maladies pulmonaires/microbiologie , Infections à mycobactéries non tuberculeuses/microbiologie , Brésil , Comorbidité , Études rétrospectives , Résultat thérapeutique , Mode de vie , Maladies pulmonaires/anatomopathologie , Maladies pulmonaires/traitement médicamenteux , Mycobactéries non tuberculeuses/isolement et purification , Infections à mycobactéries non tuberculeuses/anatomopathologie , Infections à mycobactéries non tuberculeuses/traitement médicamenteux , Antituberculeux/usage thérapeutiqueRÉSUMÉ
AbstractMycobacterium abscessus is a rapidly growing mycobacterium that has been affecting people undergoing invasive procedures, such as videosurgery and mesotherapy. This bacterium has global distribution, being found in numerous niches. The frequency of published reports of infection by rapidly growing mycobacteria associated with tattooing procedures has increased in recent years. However, in Brazil there were no case reports of M. abscessus after tattooing in the literature until now. In this paper, we describe the case of a patient with a nine-month history of lesion on a tattoo site. The diagnosis of infection with Mycobacterium abscessus was established by correlation between dermatological and histopathological aspects, culture and molecular biology techniques. The patient had significant improvement of symptoms with the use of clarithromycin monotherapy.
Sujet(s)
Adulte , Femelle , Humains , Infections à mycobactéries non tuberculeuses/étiologie , Dermatoses bactériennes/étiologie , Tatouage/effets indésirables , Brésil , Infections à mycobactéries non tuberculeuses/anatomopathologie , Mycobactéries non tuberculeuses , Dermatoses bactériennes/anatomopathologieRÉSUMÉ
Skin infections by Mycobacterium marinum are quite rare in our environment and, therefore, little studied. The majority of the lesions appear three weeks after traumas in aquariums, beaches and fish tanks. Lymph node drainage and systematization of the disease are rare and most lesions disappear in about three years. This case aims to show the effectiveness of the treatment used (lymecycline 150 mg/orally/day). This medication may be a new therapeutic option for the treatment of Mycobacterium marinum.
Sujet(s)
Adolescent , Femelle , Humains , Antibactériens/usage thérapeutique , Lymécycline/usage thérapeutique , Infections à mycobactéries non tuberculeuses/traitement médicamenteux , Mycobacterium marinum/effets des médicaments et des substances chimiques , Dermatoses bactériennes/traitement médicamenteux , Biopsie , Infections à mycobactéries non tuberculeuses/anatomopathologie , Dermatoses bactériennes/anatomopathologie , Facteurs temps , Résultat thérapeutiqueRÉSUMÉ
Around 50 mycobacteria species cause human disease. Immunosuppressive states predispose to non-tuberculous mycobaterium infection, such as Mycobacterium chelonae: AFB, non-tuberculous, fast growth of low virulence and uncommon as a human pathogen. It may compromise the skin and soft tissues, lungs, lymph nodes and there is also a disseminated presentation. The diagnosis involves AFB identification and culture on Agar and Lowenstein-Jensen medium base. A 41-year-old female with MCTD (LES predominance) is reported, presenting painless nodules in the right forearm. She denied local trauma. Immunosuppressed with prednisone and cyclophosphamide for 24 months. Lesion biopsy has demonstrated positive bacilloscopy (Ziehl-Neelsen stain) and M.chelonae in culture (Lowenstein-Jensen medium base), therefore clarithromycin treatment has been started (best therapy choice in the literature).
Sujet(s)
Adulte , Femelle , Humains , Connectivite mixte/traitement médicamenteux , Infections à mycobactéries non tuberculeuses/immunologie , Infections à mycobactéries non tuberculeuses/anatomopathologie , Mycobacterium chelonae/isolement et purification , Antibactériens/usage thérapeutique , Clarithromycine/usage thérapeutique , Immunocompétence/immunologie , Immunosuppresseurs/effets indésirables , Connectivite mixte/complications , Infections à mycobactéries non tuberculeuses/traitement médicamenteuxRÉSUMÉ
Mycobacterium chelonae es una micobacteria atípica, de rápido crecimiento, ampliamente distribuida en la naturaleza. Germen oportunista del humano y causante de infecciones de diversa gravedad. Suele ser resistente a los métodos habituales de desinfección y esterilización. Es fundamentalpara su diagnóstico y tratamiento el aislamiento del mismo y la obtención del antibiograma, ya que presenta resistencia a diferentes antibióticos. Se presentan dos casos clínicos de infección cutánea por Mycobacterium chelonae. El primero, un paciente inmunocompetente, con aislamiento de la micobacteria por punción-aspiración de las lesiones; tratado con antibióticos según antibiograma, con curación de las mismas. El segundo, una paciente inmunocomprometida no HIV, quien fue tratada con múltiples esquemas antibióticos, criocirugía, termoterapia y resección quirúrgica de las lesiones, con respuesta parcial. El presente artículo intenta actualizar conceptos sobre esta micobacteria y sus diferentes manifestaciones clínicas según el estado inmune del paciente que infecta.
Sujet(s)
Humains , Mâle , Adulte , Femelle , Infections à mycobactéries non tuberculeuses/étiologie , Infections à mycobactéries non tuberculeuses/anatomopathologie , Mycobacterium chelonae/isolement et purification , Mycobacterium chelonae/pathogénicité , Peau/microbiologie , Peau/anatomopathologie , Facteurs de risqueRÉSUMÉ
Mycobacterium fortuitum is a rapidly growing nontuberculous Mycobacterium that can cause a range of diseases in humans. Complications from M. fortuitum infection have been associated with numerous surgical procedures. A protective immune response against pathogenic mycobacterial infections is dependent on the granuloma formation. Within the granuloma, the macrophage effector response can inhibit bacterial replication and mediate the intracellular killing of bacteria. The granulomatous responses of BALB/c mice to rapidly and slowly growing mycobacteria were assessed in vivo and the bacterial loads in spleens and livers from M. fortuitum and Mycobacterium intracellulare-infected mice, as well as the number and size of granulomas in liver sections, were quantified. Bacterial loads were found to be approximately two times lower in M. fortuitum-infected mice than in M. intracellulare-infected mice and M. fortuitum-infected mice presented fewer granulomas compared to M. intracellulare-infected mice. These granulomas were characterized by the presence of Mac-1+ and CD4+ cells. Additionally, IFN-γmRNA expression was higher in the livers of M. fortuitum-infected mice than in those of M. intracellulare-infected mice. These data clearly show that mice are more capable of controlling an infection with M. fortuitum than M. intracellulare. This capacity is likely related to distinct granuloma formations in mice infected with M. fortuitum but not with M. intracellulare.
Sujet(s)
Animaux , Femelle , Souris , Granulome/anatomopathologie , Foie/immunologie , Infections à mycobactéries non tuberculeuses/anatomopathologie , Mycobacterium avium/immunologie , Mycobacterium fortuitum/immunologie , Rate/immunologie , Granulome/immunologie , Granulome , Immunité cellulaire , Immunohistochimie , Interféron gamma , Interféron gamma , Foie , Foie/anatomopathologie , Souris de lignée BALB C , Infections à mycobactéries non tuberculeuses/immunologie , Infections à mycobactéries non tuberculeuses , Infection due à Mycobacterium avium-intracellulare/immunologie , Infection due à Mycobacterium avium-intracellulare , Infection due à Mycobacterium avium-intracellulare/anatomopathologie , RT-PCR , ARN messager , ARN messager , Rate , Rate/anatomopathologie , Facteurs tempsSujet(s)
Humains , Techniques de laboratoire clinique , Mycobactéries non tuberculeuses/isolement et purification , Infections à mycobactéries non tuberculeuses/diagnostic , Dermatoses bactériennes , Infections opportunistes liées au SIDA , Sujet immunodéprimé , Mycobactéries non tuberculeuses/classification , Infections à mycobactéries non tuberculeuses/complications , Infections à mycobactéries non tuberculeuses/anatomopathologie , Mycobacterium avium , Mycobacterium chelonae , Mycobacterium fortuitum , Mycobacterium haemophilum , Mycobacterium kansasii , Mycobacterium marinum , Mycobacterium phlei , Mycobacterium scrofulaceum , Mycobacterium ulcerans , Mycobacterium xenopi , Manipulation d'échantillonsRÉSUMÉ
A 37-year-old female underwent heart transplantation for giant cell myocarditis. The patient died within three-and-a-half months of cardiac transplantation. Postmortem specimens from the heart and lung showed multiple necrotizing granulomas with numerous acid-fast bacilli. Polymerase chain reaction done on both the postmortem samples confirmed the presence of atypical mycobacterial infection. This fatal case of atypical mycobacteriosis in a cardiac transplant patient is reported for its rarity.
Sujet(s)
Adulte , Issue fatale , Femelle , Transplantation cardiaque , Humains , Poumon/anatomopathologie , Infections à mycobactéries non tuberculeuses/anatomopathologie , Myocardite/chirurgie , Myocarde/anatomopathologie , Réaction de polymérisation en chaîneRÉSUMÉ
Se hace una breve revisión de la literatura y se presenta el caso de una mujer de 32 años con lesiones esporotricoides gomosas en mano y antebrazo izquierdo. La dermatosis se presentó después de un traumatismo con una pecera doméstica. Se cultivó M. marinum y se trató con rifampicina, amikacina, isoniacida y doxiciclina, con éxito.